Correlation Between POINT Biopharma and Oric Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both POINT Biopharma and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining POINT Biopharma and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between POINT Biopharma Global and Oric Pharmaceuticals, you can compare the effects of market volatilities on POINT Biopharma and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in POINT Biopharma with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of POINT Biopharma and Oric Pharmaceuticals.

Diversification Opportunities for POINT Biopharma and Oric Pharmaceuticals

-0.3

Correlation Coefficient

POINT Biopharma  Oric Pharmaceuticals

Very good diversification

The 3 months correlation between POINT and Oric is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding POINT Biopharma Global and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and POINT Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on POINT Biopharma Global are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of POINT Biopharma i.e., POINT Biopharma and Oric Pharmaceuticals go up and down completely randomly.

Pair Corralation between POINT Biopharma and Oric Pharmaceuticals

If you would invest  948.00  in Oric Pharmaceuticals on September 5, 2024 and sell it today you would earn a total of  12.00  from holding Oric Pharmaceuticals or generate 1.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	4.55%
Values	Daily Returns

POINT Biopharma Global  vs.  Oric Pharmaceuticals

POINT Biopharma Global

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days POINT Biopharma Global has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, POINT Biopharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Oric Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Oric Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound forward indicators, Oric Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with POINT Biopharma and Oric Pharmaceuticals

The main advantage of trading using opposite POINT Biopharma and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if POINT Biopharma position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.

The idea behind POINT Biopharma Global and Oric Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.